Deutsche Bank AG reduced its stake in shares of Anthem Inc (NYSE:ANTM) by 98.1% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 621,677 shares of the company’s stock after selling 31,941,056 shares during the period. Deutsche Bank AG’s holdings in Anthem were worth $139,878,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds also recently bought and sold shares of the company. Allianz Asset Management GmbH lifted its holdings in Anthem by 66.0% in the 4th quarter. Allianz Asset Management GmbH now owns 1,603,619 shares of the company’s stock worth $360,830,000 after purchasing an additional 637,439 shares in the last quarter. Farallon Capital Management LLC lifted its holdings in Anthem by 291.9% in the 4th quarter. Farallon Capital Management LLC now owns 823,000 shares of the company’s stock worth $185,183,000 after purchasing an additional 613,000 shares in the last quarter. Atlantic Trust Group LLC purchased a new position in Anthem in the 3rd quarter worth approximately $88,799,000. Vulcan Value Partners LLC lifted its holdings in Anthem by 52.1% in the 4th quarter. Vulcan Value Partners LLC now owns 1,327,283 shares of the company’s stock worth $298,652,000 after purchasing an additional 454,892 shares in the last quarter. Finally, Nordea Investment Management AB lifted its holdings in Anthem by 8.7% in the 3rd quarter. Nordea Investment Management AB now owns 4,215,569 shares of the company’s stock worth $800,452,000 after purchasing an additional 339,111 shares in the last quarter. 87.32% of the stock is currently owned by hedge funds and other institutional investors.
A number of research firms recently commented on ANTM. Barclays began coverage on Anthem in a report on Thursday. They issued an “overweight” rating and a $270.00 price target on the stock. ValuEngine raised Anthem from a “hold” rating to a “buy” rating in a report on Friday, February 2nd. Credit Suisse Group reissued an “outperform” rating and issued a $280.00 price target (up from $255.00) on shares of Anthem in a report on Thursday, February 1st. Morgan Stanley boosted their price target on Anthem from $247.00 to $266.00 and gave the stock an “equal weight” rating in a report on Thursday, February 1st. Finally, Wells Fargo & Co boosted their price target on Anthem from $260.00 to $275.00 and gave the stock an “outperform” rating in a report on Thursday, February 1st. Four equities research analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company’s stock. Anthem currently has a consensus rating of “Buy” and a consensus price target of $233.25.
Anthem (NYSE:ANTM) last released its quarterly earnings data on Wednesday, January 31st. The company reported $1.29 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.25 by $0.04. Anthem had a return on equity of 12.29% and a net margin of 4.27%. The business had revenue of $22.45 billion for the quarter, compared to the consensus estimate of $22.17 billion. During the same quarter in the previous year, the company posted $1.76 EPS. The company’s revenue was up 4.5% compared to the same quarter last year. sell-side analysts expect that Anthem Inc will post 15.09 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, March 23rd. Shareholders of record on Friday, March 9th will be paid a $0.75 dividend. This is an increase from Anthem’s previous quarterly dividend of $0.70. The ex-dividend date of this dividend is Thursday, March 8th. This represents a $3.00 dividend on an annualized basis and a yield of 1.29%. Anthem’s payout ratio is presently 20.89%.
Anthem declared that its board has authorized a stock buyback plan on Thursday, December 7th that authorizes the company to buyback $5.00 billion in outstanding shares. This buyback authorization authorizes the company to reacquire shares of its stock through open market purchases. Shares buyback plans are often an indication that the company’s board believes its stock is undervalued.
In other news, SVP Ronald W. Penczek sold 1,966 shares of the business’s stock in a transaction that occurred on Wednesday, March 7th. The stock was sold at an average price of $231.90, for a total transaction of $455,915.40. Following the transaction, the senior vice president now owns 2,132 shares of the company’s stock, valued at approximately $494,410.80. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Joseph Swedish sold 67,500 shares of the business’s stock in a transaction that occurred on Thursday, January 11th. The shares were sold at an average price of $235.87, for a total value of $15,921,225.00. Following the transaction, the insider now directly owns 134,043 shares in the company, valued at approximately $31,616,722.41. The disclosure for this sale can be found here. In the last ninety days, insiders sold 200,720 shares of company stock worth $47,512,932. Corporate insiders own 0.36% of the company’s stock.
Anthem, Inc is a health benefits company. The Company operates through three segments: Commercial and Specialty Business, Government Business and Other. It offers a spectrum of network-based managed care plans to large and small employer, individual, Medicaid and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; indemnity plans and other hybrid plans, including consumer-driven health plans; and hospital only and limited benefit products.
Want to see what other hedge funds are holding ANTM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Anthem Inc (NYSE:ANTM).
Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.